symbol,statement_type,period_end,line_item,value
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,580801623.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,580801623.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,23727300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,82628700000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,284146000000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,405950000000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,124801200000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,284146000000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,3211900000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,326533200000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,342149700000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,326469300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,-63900000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,326533200000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,325952400000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,580800000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,580800000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,171380400000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,24557000000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,545400000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tradeand Other Payables Non Current,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Revenue,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,3032700000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,18008600000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,2392100000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,15616500000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,2829300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,146823400000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,5468300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Deferred Taxes Liabilities,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,64620100000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,819800000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,63800300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,2755600000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Payables,44737800000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,2849300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,41888500000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,497849700000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,226225100000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,2938500000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Defined Pension Benefit,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,12929600000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,7438700000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Held To Maturity Securities,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,7438700000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Trading Securities,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Equity Investment,455400000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentsin Joint Venturesat Cost,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentsin Associatesat Cost,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,42387200000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,36207000000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,6180200000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,154554300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,154554300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,32660000000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,121894300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Properties,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,271624600000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,23570200000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Hedging Assets Current,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Assets Held For Sale Current,0.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Inventory,105437200000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Inventories Adjustments Allowances,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Inventories,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,155600000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Taxes Receivable,27800000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,57459300000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,84974500000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,29285000000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,55689500000.0
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
AUROPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,585938609.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,585938609.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,29217400000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,66476300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,257661900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,361580200000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,120065000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,257661900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,3324100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,298428000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,319777000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,298508000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,80000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,298428000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,297842100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,268014200000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,5295100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,585900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,585900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,152207100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,30215800000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,364700000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,2257000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tradeand Other Payables Non Current,1200000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Revenue,363500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,3565600000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,23874300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,2525300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,21349000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,2257000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,121991300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,2803300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Deferred Taxes Liabilities,2490100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,42602000000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,798800000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,41803200000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,2567900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,2567900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Payables,55648300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,11076500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,30200000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,2490100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,44541600000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,450715100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,208658800000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,2299600000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Defined Pension Benefit,10800000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,5819300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,12126400000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,1516100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Held To Maturity Securities,893400000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,471200000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,151500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Trading Securities,
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Equity Investment,1700500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentsin Joint Venturesat Cost,1603300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentsin Associatesat Cost,97200000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,40766100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,34814600000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,5951500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,144116900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-63726900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,207843800000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,28661800000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,115455100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,120234900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,49160600000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,9786500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,242056300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,25364300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Hedging Assets Current,34500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Assets Held For Sale Current,4337100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,37100000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,22857600000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Inventory,98082300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Inventories Adjustments Allowances,-22400000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Inventories,4683300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,45609500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,15770300000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,32041600000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,5278400000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Taxes Receivable,56700000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,48167400000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-1232500000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,49399900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,63251700000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,29316900000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,33934800000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,20115700000.0
AUROPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,13819100000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,585938609.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,585938609.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,4652300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,52862100000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,229179300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,317013700000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,100518900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,229179300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,4246900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,268398500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,274588100000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,268518500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,120000000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,268398500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,267812600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,240130300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,4268900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,585900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,585900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,130381400000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,15443600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,-15153200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,1727200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tradeand Other Payables Non Current,290400000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Revenue,0.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,3896100000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,9404900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,3215300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,6189600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,1727200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,114937800000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,2235900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Deferred Taxes Liabilities,2116000000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,43457200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,1031600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,42425600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,2005300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,2005300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Payables,47554600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,8816600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,24900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,2116000000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,38713100000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,398899900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,183443200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,45300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Defined Pension Benefit,45300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,4766100000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,6774900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,2281600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Held To Maturity Securities,1511500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,618600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,151500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Trading Securities,1511500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Equity Investment,1683600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentsin Joint Venturesat Cost,1587900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentsin Associatesat Cost,95700000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,39219200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,33258500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,5960700000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,128036000000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-55593500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,183629500000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,48082200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,79953800000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,90081700000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,35920400000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,9545200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,215456700000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,18687000000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Hedging Assets Current,191400000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Assets Held For Sale Current,857600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,115700000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,16799600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Inventory,85112300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Inventories Adjustments Allowances,-48800000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Inventories,3784800000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,37272900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,14068300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,30035100000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,5480000000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Taxes Receivable,756200000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,44663800000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-1216600000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,45880400000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,62236300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,18273400000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,43962900000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,25931300000.0
AUROPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,18031600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,585938609.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,585938609.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,32789600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,209626900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,273764400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,99667100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,209626900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,4785000000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,245759800000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,248251900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,245740500000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,-19300000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,245759800000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,245173900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,225190100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,4268900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,585900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,585900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,93476700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,11916900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,297700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,1717900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tradeand Other Payables Non Current,297700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Revenue,
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,4109600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,5678200000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,3186100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,2492100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,1717900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,81559800000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,1279400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Deferred Taxes Liabilities,580300000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,27111400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,1598900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,25512500000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,1705600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,1705600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Payables,33869700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,6813500000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,25700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,580300000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,27030500000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,339217200000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,157990300000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Defined Pension Benefit,
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,1461200000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,2885900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,3327400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Held To Maturity Securities,
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,915900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,151500000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Trading Securities,2260000000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Equity Investment,2855600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentsin Joint Venturesat Cost,2748000000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentsin Associatesat Cost,107600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,36132900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,31378700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,4754200000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,107699100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-38680300000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,146379400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,30414800000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,6992600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,79741900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,28410900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,7811800000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,181226900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,15550100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Hedging Assets Current,320200000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Assets Held For Sale Current,791000000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,112200000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,12319700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Inventory,75538500000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Inventories Adjustments Allowances,
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Inventories,3402700000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,33545500000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,11978400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,26611900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,3746400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Taxes Receivable,2699900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,40122600000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-921300000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,41043900000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,45576400000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,3951300000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,41625100000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,6297200000.0
AUROPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,35327900000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,201367600000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,4268900000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,1571100000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tradeand Other Payables Non Current,395000000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Revenue,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Deferred Taxes Liabilities,2103500000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,1719300000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Payables,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,8535000000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,26000000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Defined Pension Benefit,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,5098400000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Held To Maturity Securities,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,151500000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Trading Securities,1540000000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Equity Investment,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentsin Joint Venturesat Cost,2620700000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentsin Associatesat Cost,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-31457100000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,67542500000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,24176800000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,2860100000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Hedging Assets Current,198200000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Assets Held For Sale Current,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,128700000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,9650000000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Inventories Adjustments Allowances,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Inventories,3549800000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,41186300000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,13024800000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,32504800000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Taxes Receivable,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-949900000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,35982700000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,6500000.0
AUROPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,53728200000.0
